Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sufentanil disposition during cardiopulmonary bypass.

P Flezzani1, M J Alvis, J R Jacobs

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710.

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|November 1, 1987
PubMed
Summary

Computer-assisted continuous infusion (CACI) systems can maintain stable sufentanil plasma levels during cardiopulmonary bypass (CPB). However, this pharmacokinetic approach may lead to drug accumulation during CPB.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The alleviating effect of dietary electrolyte balance levels on heat stress <i>via</i> regulating water and ion metabolism in Pekin ducks.

British poultry science·2026
Same author

[Evaluation of the performance of the artificial intelligence - enabled snail identification system for recognition of <i>Oncomelania hupensis robertsoni</i> and <i>Tricula</i>].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025
Same author

Comparing the Robustness of Intensity-modulated Proton Therapy and Proton-arc Therapy Against Interplay Effects of 4D Robust-optimised Plans for Lung Stereotactic Body Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

[Construction of a visual intelligent identification model for <i>Oncomelania hupensis robertsoni</i> in Yunnan Province based on the EfficientNet-B4 model].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025
Same author

[Preliminary observation on the development and dynamic changes of chronic toxoplasmosis in mice].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2024
Same author

The association between mammographic density and breast cancer molecular subtypes: a systematic review and meta-analysis.

Clinical radiology·2023

Area of Science:

  • Anesthesiology
  • Pharmacokinetics
  • Cardiovascular Surgery

Background:

  • Maintaining stable anesthetic drug concentrations is critical during cardiopulmonary bypass (CPB).
  • Computer-assisted continuous infusion (CACI) offers potential for precise drug delivery.
  • Sufentanil is a potent opioid commonly used in cardiac anesthesia.

Purpose of the Study:

  • To evaluate the efficacy of a CACI system in maintaining target sufentanil plasma concentrations during CPB.
  • To assess the pharmacokinetic behavior of sufentanil using a CACI system in surgical patients.

Main Methods:

  • Ten patients undergoing CPB received sufentanil via CACI, targeting a central compartment concentration of 5 ng/mL.
  • Pharmacokinetic data, including plasma sufentanil levels, were collected before, during, and up to 90 minutes after CPB initiation.

Related Experiment Videos

  • Physiological parameters like hematocrit, protein levels, and temperatures were also monitored.
  • Main Results:

    • Sufentanil plasma concentrations reached 3.8 ± 0.4 ng/mL before CPB.
    • During CPB, concentrations approached the target of 5 ng/mL, reaching 4.7 ± 0.4 ng/mL.
    • The CACI system demonstrated the ability to achieve and maintain relatively stable sufentanil levels.

    Conclusions:

    • Pharmacokinetically guided CACI can achieve stable sufentanil plasma levels during CPB.
    • The data suggest a potential for sufentanil accumulation during CPB when using this infusion strategy.
    • Further research is warranted to optimize CACI protocols and mitigate potential drug accumulation.